Clinical Trials
3 trialsNCT06722911 2024-12-09
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
Zhejiang Provincial People's Hospital
Phase 2 Recruiting
NCT04224402 2023-02-15
Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.
Sun Yat-sen University
Phase 2 Completed
NCT03344172 2020-05-14
17-134
University of Pittsburgh
Phase 2 Terminated